High-throughput non-invasive prenatal testing for fetal rhesus D status in RhD-negative women not known to be sensitised to the RhD antigen: a systematic review and economic evaluation
Background: High-throughput non-invasive prenatal testing (NIPT) for fetal rhesus (D antigen) (RhD) status could avoid unnecessary treatment with routine anti-D immunoglobulin for RhD-negative women carrying a RhD-negative fetus, although this may lead to an increased risk of RhD sensitisations. Obj...
Main Authors: | Pedro Saramago, Huiqin Yang, Alexis Llewellyn, Ruth Walker, Melissa Harden, Stephen Palmer, Susan Griffin, Mark Simmonds |
---|---|
Format: | Article |
Language: | English |
Published: |
NIHR Journals Library
2018-03-01
|
Series: | Health Technology Assessment |
Online Access: | https://doi.org/10.3310/hta22130 |
Similar Items
-
High-throughput, non-invasive prenatal testing for fetal rhesus D status in RhD-negative women: a systematic review and meta-analysis
by: Huiqin Yang, et al.
Published: (2019-02-01) -
Caracterização molecular dos antigenos RhD, (RhD fraco e RhD parcial) e sua aplicação na pratica transfusional
by: Rodrigues, Artemis Socorro do Nascimento
Published: (2005) -
Molecular characterization of RhD(-)Taiwanese
by: Peter Shu, et al.
Published: (2006) -
Grupos sanguíneos ABO, RhD y esclerosis múltiple ABO and RhD blood groups in multiple sclerosis
by: Leslie Pérez-Ruiz, et al.
Published: (2011-06-01) -
Usefulness of prenatal detection of RhD typing by molecular analysis in Indians
by: Kulkarni S, et al.
Published: (2007-01-01)